IL95103A - Pyrimidine (4-thionoclycosides prepared and pharmaceutical preparations containing them - Google Patents
Pyrimidine (4-thionoclycosides prepared and pharmaceutical preparations containing themInfo
- Publication number
- IL95103A IL95103A IL9510390A IL9510390A IL95103A IL 95103 A IL95103 A IL 95103A IL 9510390 A IL9510390 A IL 9510390A IL 9510390 A IL9510390 A IL 9510390A IL 95103 A IL95103 A IL 95103A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- formula
- deoxy
- thiouridine
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898916323A GB8916323D0 (en) | 1989-07-17 | 1989-07-17 | Nucleosides |
| GB898922393A GB8922393D0 (en) | 1989-10-04 | 1989-10-04 | Antiviral pyrimidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL95103A0 IL95103A0 (en) | 1991-06-10 |
| IL95103A true IL95103A (en) | 1996-03-31 |
Family
ID=26295621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL9510390A IL95103A (en) | 1989-07-17 | 1990-07-17 | Pyrimidine (4-thionoclycosides prepared and pharmaceutical preparations containing them |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5356882A (pt) |
| EP (1) | EP0409575A1 (pt) |
| JP (1) | JP2502813B2 (pt) |
| KR (1) | KR927003616A (pt) |
| AT (1) | ATE161267T1 (pt) |
| AU (3) | AU648746B2 (pt) |
| CA (1) | CA2065279A1 (pt) |
| FI (1) | FI920197A0 (pt) |
| HU (1) | HUT59694A (pt) |
| IE (1) | IE902574A1 (pt) |
| IL (1) | IL95103A (pt) |
| LV (1) | LV10104B (pt) |
| MX (1) | MX9203668A (pt) |
| MY (1) | MY105944A (pt) |
| NO (1) | NO178930C (pt) |
| NZ (1) | NZ234534A (pt) |
| PL (1) | PL167317B1 (pt) |
| PT (1) | PT94731B (pt) |
| WO (1) | WO1991001326A1 (pt) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6903224B2 (en) | 1988-04-11 | 2005-06-07 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes |
| US7119202B1 (en) | 1989-02-08 | 2006-10-10 | Glaxo Wellcome Inc. | Substituted-1,3-oxathiolanes and substituted-1,3-dioxolanes with antiviral properties |
| US5270315A (en) * | 1988-04-11 | 1993-12-14 | Biochem Pharma Inc. | 4-(purinyl bases)-substituted-1,3-dioxlanes |
| US6350753B1 (en) | 1988-04-11 | 2002-02-26 | Biochem Pharma Inc. | 2-Substituted-4-substituted-1,3-dioxolanes and use thereof |
| UA45942A (uk) * | 1989-02-08 | 2002-05-15 | Біокем Фарма, Інк. | 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція |
| GB9009861D0 (en) | 1990-05-02 | 1990-06-27 | Glaxo Group Ltd | Chemical compounds |
| US5521163A (en) * | 1990-07-13 | 1996-05-28 | University Of Birmingham | Antiviral pyrimidine nucleosides and methods for using same |
| US5643913A (en) * | 1990-07-19 | 1997-07-01 | Glaxo Wellcome Inc. | Pharmaceutical compositions of 5-substituted uracil compounds |
| ATE161722T1 (de) | 1990-07-19 | 1998-01-15 | Wellcome Found | Enzyminaktivatoren |
| GB9020930D0 (en) * | 1990-09-26 | 1990-11-07 | Wellcome Found | Pharmaceutical combinations |
| US5587480A (en) * | 1990-11-13 | 1996-12-24 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties |
| US6369066B1 (en) | 1990-11-13 | 2002-04-09 | Biochem Pharma, Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
| US6228860B1 (en) | 1990-11-13 | 2001-05-08 | Biochem Pharma Inc. | Substituted 1,3-oxathiolanes with antiviral properties |
| IL100502A (en) * | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | PHARMACEUTICAL PREPARATIONS CONTAINING CIS-4-AMINO-1-) 2-HYDROXIMETHIL-1,3-OXETYOLEN-5-IL (- |
| DE4110977A1 (de) * | 1991-04-05 | 1992-10-08 | Bayer Ag | Substituierte 2',3'-didesoxy-5-trifluormethyluridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| GB9109186D0 (en) * | 1991-04-29 | 1991-06-19 | Wellcome Found | Preparation of thionucleosides |
| GB9110874D0 (en) * | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
| ZA923641B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
| WO1994001117A1 (en) * | 1992-07-02 | 1994-01-20 | The Wellcome Foundation Limited | Therapeutic nucleosides |
| CN1087089A (zh) * | 1992-07-02 | 1994-05-25 | 惠尔康基金会集团公司 | 治疗核苷 |
| GB9218810D0 (en) * | 1992-09-04 | 1992-10-21 | Univ Birmingham | Antiviral pyrimidine nucleosides |
| AU4125099A (en) * | 1998-06-01 | 1999-12-20 | S & T Science And Technology Inc. | Antiviral phosphorus derivatives of 4'-thio-5-ethyl-2'-deoxyuridine |
| KR20000008131A (ko) * | 1998-07-10 | 2000-02-07 | 정낙신 | 치오뉴클레오시드 유도체 및 그들의 제조방법 |
| US6653318B1 (en) | 1999-07-21 | 2003-11-25 | Yale University | 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use |
| US7589077B2 (en) | 2001-05-18 | 2009-09-15 | Rakesh Kumar | Antiviral nucleosides |
| US7211570B2 (en) * | 2001-12-20 | 2007-05-01 | Pharmasset, Inc. | Treatment of EBV and KHSV infection |
| JP3677510B2 (ja) * | 2002-08-22 | 2005-08-03 | 株式会社ジェネティックラボ | ４’−チオヌクレオチド |
| WO2009034945A1 (ja) * | 2007-09-10 | 2009-03-19 | Yamasa Corporation | エプスタイン・バールウイルス関連疾患に対する薬剤およびそのスクリーニング法 |
| WO2022008025A1 (en) * | 2020-07-05 | 2022-01-13 | Since & Technology Development Fund Authority | 2-hydroxyiminopyrimidine nucleosides and derivitives and antiviral uses thereto |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4211773A (en) * | 1978-10-02 | 1980-07-08 | Sloan Kettering Institute For Cancer Research | 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides |
| US4383990A (en) * | 1980-10-01 | 1983-05-17 | Beecham Group Limited | Antiviral agents, their preparation and use |
| DE3102136A1 (de) * | 1981-01-23 | 1982-08-19 | Bayer Ag, 5090 Leverkusen | Neue verbindung bay i 3265 komponente a, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE3236389A1 (de) * | 1982-10-01 | 1984-04-05 | Bayer Ag, 5090 Leverkusen | Neue nucleosidverbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE3341571A1 (de) * | 1983-11-17 | 1985-05-30 | Bayer Ag, 5090 Leverkusen | Neue antibiotika, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel und zwischenprodukte zu ihrer herstellung |
| GB8629892D0 (en) * | 1986-12-15 | 1987-01-28 | Wellcome Found | Antiviral compounds |
| US5159067A (en) * | 1987-01-28 | 1992-10-27 | University Of Georgia Research Foundation Inc. | 5'-Diphosphohexose nucleoside pharmaceutical compositions |
| SE8701605D0 (sv) * | 1987-04-16 | 1987-04-16 | Astra Ab | Novel medicinal compounds |
| US5215970A (en) * | 1987-04-16 | 1993-06-01 | Medivir Ab | Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds |
| EP0516186A3 (en) * | 1987-04-16 | 1993-01-13 | Medivir Aktiebolag | Nucleosides and nucleoside analogues, pharmaceutical composition and processes for the preparation of the compounds |
| DE3725554A1 (de) * | 1987-08-01 | 1989-02-09 | Hoechst Ag | Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung |
| ZA898567B (en) * | 1988-11-15 | 1990-08-29 | Merrell Dow Pharma | Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine,uridine and guanosine derivatives |
| ES2253732T3 (es) * | 1989-09-15 | 2006-06-01 | Southern Research Institute | 2'-deoxi-4'-tioribonucleosidos como agentes antivirales y anticancerosos. |
| IE74701B1 (en) * | 1989-10-04 | 1997-07-30 | Univ Birmingham | Further antiviral pyrimidine nucleosides |
| US5128458A (en) * | 1990-04-20 | 1992-07-07 | Southern Research Institute | 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
| DE4021006A1 (de) * | 1990-07-02 | 1992-01-09 | Hoechst Ag | Pyrimidin-derivate, deren herstellung und verwendung sowie diese enthaltende arzneimittel |
| SE9003151D0 (sv) * | 1990-10-02 | 1990-10-02 | Medivir Ab | Nucleoside derivatives |
| FR2668153B1 (fr) * | 1990-10-22 | 1995-03-31 | Pasteur Merieux Serums Vacc | Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant. |
-
1990
- 1990-07-16 IE IE257490A patent/IE902574A1/en unknown
- 1990-07-16 NZ NZ234534A patent/NZ234534A/en unknown
- 1990-07-17 CA CA002065279A patent/CA2065279A1/en not_active Abandoned
- 1990-07-17 HU HU92143A patent/HUT59694A/hu unknown
- 1990-07-17 AT AT90307820T patent/ATE161267T1/de not_active IP Right Cessation
- 1990-07-17 JP JP2510031A patent/JP2502813B2/ja not_active Expired - Lifetime
- 1990-07-17 WO PCT/GB1990/001099 patent/WO1991001326A1/en active Application Filing
- 1990-07-17 AU AU59634/90A patent/AU648746B2/en not_active Ceased
- 1990-07-17 IL IL9510390A patent/IL95103A/en not_active IP Right Cessation
- 1990-07-17 MY MYPI90001198A patent/MY105944A/en unknown
- 1990-07-17 KR KR1019920700091A patent/KR927003616A/ko not_active Application Discontinuation
- 1990-07-17 PL PL90286088A patent/PL167317B1/pl unknown
- 1990-07-17 EP EP90307820A patent/EP0409575A1/en active Granted
- 1990-07-17 PT PT94731A patent/PT94731B/pt not_active IP Right Cessation
-
1992
- 1992-01-16 NO NO920210A patent/NO178930C/no unknown
- 1992-01-16 FI FI920197A patent/FI920197A0/fi unknown
- 1992-06-29 MX MX9203668A patent/MX9203668A/es unknown
-
1993
- 1993-03-10 LV LVP-93-177A patent/LV10104B/en unknown
- 1993-06-30 US US08/084,433 patent/US5356882A/en not_active Expired - Fee Related
-
1994
- 1994-02-23 AU AU56353/94A patent/AU668270B2/en not_active Expired - Fee Related
- 1994-02-23 AU AU56352/94A patent/AU669040B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT94731B (pt) | 1997-04-30 |
| AU669040B2 (en) | 1996-05-23 |
| KR927003616A (ko) | 1992-12-18 |
| NO178930C (no) | 1996-07-03 |
| JPH04506661A (ja) | 1992-11-19 |
| HU9200143D0 (en) | 1992-04-28 |
| AU5963490A (en) | 1991-02-22 |
| NO920210L (no) | 1992-01-16 |
| AU5635294A (en) | 1994-05-19 |
| LV10104B (en) | 1995-08-20 |
| NO920210D0 (no) | 1992-01-16 |
| AU668270B2 (en) | 1996-04-26 |
| EP0409575A1 (en) | 1991-01-23 |
| AU5635394A (en) | 1994-05-05 |
| HUT59694A (en) | 1992-06-29 |
| NZ234534A (en) | 1994-12-22 |
| MX9203668A (es) | 1992-09-01 |
| IE902574A1 (en) | 1991-02-27 |
| US5356882A (en) | 1994-10-18 |
| WO1991001326A1 (en) | 1991-02-07 |
| MY105944A (en) | 1995-02-28 |
| NO178930B (no) | 1996-03-25 |
| FI920197A0 (fi) | 1992-01-16 |
| CA2065279A1 (en) | 1991-01-18 |
| ATE161267T1 (de) | 1998-01-15 |
| LV10104A (lv) | 1994-05-10 |
| PT94731A (pt) | 1991-03-20 |
| JP2502813B2 (ja) | 1996-05-29 |
| PL286088A1 (en) | 1991-11-04 |
| IL95103A0 (en) | 1991-06-10 |
| AU648746B2 (en) | 1994-05-05 |
| PL167317B1 (pl) | 1995-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU648746B2 (en) | Antiviral pyrimidine nucleosides | |
| AU656122B2 (en) | Further antiviral pyrimidine nucleosides | |
| US5079235A (en) | Antiviral compounds | |
| CA2143834A1 (en) | Antiviral pyrimidine nucleosides | |
| US4863906A (en) | 2'-deoxy-5-ethynyluridine-3',5'-diestens for treatment of VZV and CMV infections | |
| JP4076114B2 (ja) | ４’−ｃ−エチニルプリンヌクレオシド化合物 | |
| US5521163A (en) | Antiviral pyrimidine nucleosides and methods for using same | |
| AU635834B2 (en) | Antiviral compounds | |
| NZ247461A (en) | 2'-deoxy-5-ethyl-4'-thio-beta-uridine, preparation and pharmaceutical compositions | |
| NZ244365A (en) | 4-thio sugar derivatives and their preparation; use as intermediates | |
| US5028596A (en) | 1-(β-D-arabinofuranosyl)-5-propynyluracil for treatment of VZV infections | |
| JP4039790B2 (ja) | ４’−ｃ−エチニルピリミジンヌクレオシド化合物 | |
| LT3466B (en) | Pyrimidine nucleosides, process for their preparation, compositions and intermediates | |
| JPH05331184A (ja) | 抗ウイルス化合物 | |
| JPH0987295A (ja) | ２’−デオキシ−２’−メチリデン−４’−チオピリミジンヌクレオシド及び抗ウイルス剤 | |
| JP2008110983A (ja) | ４’−ｃ−エチニルヌクレオシド化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| RH | Patent void |